Detalhe da pesquisa
1.
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.
Circulation
; 147(16): 1192-1203, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779348
2.
Estimating and Presenting Hazard Ratios and Absolute Risks from a Cox Model with Complex Non-linear Interactions.
Am J Epidemiol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775274
3.
Variation in risk-adjusted cardiac intensive care unit (CICU) length of stay and the association with in-hospital mortality: An analysis from the Critical Care Cardiology Trials Network (CCCTN) registry.
Am Heart J
; 271: 28-37, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369218
4.
Prognostic performance of the IABP-SHOCK II Risk Score among cardiogenic shock subtypes in the critical care cardiology trials network registry.
Am Heart J
; 270: 1-12, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190931
5.
Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70.
Circulation
; 145(18): 1377-1386, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35369705
6.
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
Circulation
; 146(18): 1344-1356, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036760
7.
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
Circulation
; 143(7): 673-684, 2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587659
8.
Inhibition of p38 MAP kinase in patients with ST-elevation myocardial infarction - findings from the LATITUDE-TIMI 60 trial.
Am Heart J
; 243: 147-157, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34508693
9.
The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry.
Crit Care Med
; 49(8): 1293-1302, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33861557
10.
Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the Critical Care Cardiology Trials Network Registry.
Am Heart J
; 222: 8-14, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32006910
11.
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Circulation
; 137(15): 1571-1582, 2018 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29263150
12.
Inflammatory and Cholesterol Risk in the FOURIER Trial.
Circulation
; 138(2): 131-140, 2018 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29530884
13.
Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACS.
Clin Chem Lab Med
; 57(7): 1084-1092, 2019 06 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30710475
14.
Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Circulation
; 136(25): 2440-2450, 2017 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28972004
15.
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial.
Lancet
; 390(10106): 1962-1971, 2017 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28859947
16.
Cardiovascular Benefit of Lowering Low-Density Lipoprotein Cholesterol Below 40 mg/dL.
Circulation
; 144(21): 1732-1734, 2021 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452583
17.
The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
Eur Heart J
; 37(48): 3576-3584, 2016 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27569841
18.
Depot medroxyprogesterone acetate in combination with a twice-daily lopinavir-ritonavir-based regimen in HIV-infected women showed effective contraception and a lack of clinically significant interactions, with good safety and tolerability: results of the ACTG 5283 study.
Antimicrob Agents Chemother
; 59(4): 2094-101, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25624326
19.
Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.
Antimicrob Agents Chemother
; 59(6): 3399-405, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25824215
20.
Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)".
Circulation
; 137(24): 2662-2663, 2018 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29891625